|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
24 August 2015 |
|
Main ID: |
NCT02268799 |
|
Date of registration:
|
15/10/2014 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
High Sensitivity Troponin T Levels Following DC Cardioversion for Atrial Fibrillation / Atrial Flutter
|
|
Scientific title:
|
High Sensitivity Troponin T Levels Following Elective External Direct Current Cardioversion for Atrial Fibrillation / Atrial Flutter |
|
Date of first enrolment:
|
October 2014 |
|
Target sample size:
|
101 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02268799 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Case-Only, Time Perspective: Prospective
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Ireland
| | | | | | | |
|
Contacts
|
|
Name:
|
Thomas J Kiernan, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University of Limerick |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patients with atrial fibrillation / atrial flutter attending for direct current
external cardioversion
- Age 18 or older
Exclusion Criteria:
- Myocardial infarction within the last 6 weeks
- Coronary artery bypass grafting, percutaneous coronary intervention or any other
invasive cardiac procedure within the last 6 weeks
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Atrial Flutter
|
|
Atrial Fibrillation
|
|
Primary Outcome(s)
|
|
High Sensitivity Troponin T levels pre and 6 hours post cardioversion
[Time Frame: 1 year]
|
|
Secondary Outcome(s)
|
|
Creatine Kinase levels pre and 6 hours post cardioversion
[Time Frame: 1 year]
|
|
B-type Natriuretic Peptide (BNP) levels pre and 6 hours post cardioversion
[Time Frame: 1 year]
|
|
Neutrophil Gelatinase-associated Lipocalin (NGAL) levels pre and 6 hours post cardioversion
[Time Frame: 1 year]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|